Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

OCGN

Ocugen Inc

Feb 21 • 04:00PM ET

0.6800

Dollar change -0.0202
Percentage change -2.88	%

Healthcare • Biotechnology • USA • NASD

Peers: PFE MRNA BNTX NVAX INO VXRT SAGE MCRB ADMA VTVT

| Held by: VTI IWM VXF IWO VTWO VHT IWC MOON ITOT VTWG

Index	RUT	P/E	-	EPS (ttm)	-0.18	Insider Own	1.82%	Shs Outstand	290.26M	Perf Week	-3.23%
Market Cap	197.84M	Forward P/E	-	EPS next Y	-0.25	Insider Trans	0.67%	Shs Float	285.66M	Perf Month	-10.09%
Income	-46.16M	PEG	-	EPS next Q	-0.05	Inst Own	24.78%	Short Float	20.61%	Perf Quarter	-25.37%
Sales	4.70M	P/S	42.09	EPS this Y	23.08%	Inst Trans	-10.21%	Short Ratio	12.87	Perf Half Y	-43.80%
Book/sh	0.14	P/B	4.86	EPS next Y	-25.00%	ROA	-74.87%	Short Interest	58.88M	Perf Year	-34.62%
Cash/sh	0.13	P/C	5.11	EPS next 5Y	4.71%	ROE	-103.30%	52W Range	0.64 - 2.11	Perf YTD	-15.53%
Dividend Est.	-	P/FCF	-	EPS past 5Y	41.20%	ROI	-101.17%	52W High	-67.70%	Beta	3.87
Dividend TTM	-	Quick Ratio	2.58	Sales past 5Y	10.65%	Gross Margin	67.04%	52W Low	6.18%	ATR (14)	0.05
Dividend Ex-Date	-	Current Ratio	2.58	EPS Y/Y TTM	45.81%	Oper. Margin	-1115.79%	RSI (14)	40.77	Volatility	5.85% 6.44%
Employees	65	Debt/Eq	0.17	Sales Y/Y TTM	-	Profit Margin	-982.04%	Recom	1.00	Target Price	6.50
Option/Short	Yes / Yes	LT Debt/Eq	0.12	EPS Q/Q	15.58%	Payout	-	Rel Volume	0.55	Prev Close	0.70
Sales Surprise	184.00%	EPS Surprise	9.09%	Sales Q/Q	-	Earnings	Mar 05 BMO	Avg Volume	4.58M	Price	0.68
SMA20	-5.34%	SMA50	-11.78%	SMA200	-41.71%	Trades		Volume	2,504,145	Change	-2.88%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-15-24	Initiated	Maxim Group	Buy	$4
Mar-01-23	Upgrade	Chardan Capital Markets	Neutral → Buy	$3.50
Aug-23-22	Initiated	Mizuho	Buy	$5
Jun-15-22	Resumed	ROTH Capital	Buy	$8
Jun-02-22	Initiated	Cantor Fitzgerald	Overweight	$4.50
Jul-26-21	Initiated	Noble Capital Markets	Outperform
Jun-11-21	Downgrade	ROTH Capital	Buy → Neutral	$10 → $6
May-07-21	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Feb-09-21	Downgrade	Chardan Capital Markets	Buy → Neutral	$0.70 → $13
Feb-04-21	Upgrade	H.C. Wainwright	Neutral → Buy	$4.50

Feb-21-25 08:00AM	Ocugen to Host Conference Call on Wednesday, March 5, 2025 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-13-25 05:41PM	Why Ocugen (OCGN) Is Advancing Today (Insider Monkey) +6.47%
Feb-12-25 07:42AM	Ocugen, Inc. Announces Dosing Completion in the Phase 2 ArMaDa Clinical Trial for OCU410-a Multifunctional Modifier Gene Therapy for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration (GlobeNewswire)
Feb-03-25 06:30AM	Ocugen Announces Positive Opinion of European Medicines Agency's Committee for Advanced Therapies for Advanced Therapy Medicinal Product Classification for Modifier Gene Therapy Candidate OCU400 for Retinitis Pigmentosa (GlobeNewswire)
Jan-27-25 06:30AM	Ocugen, Inc. Announces Investigational New Drug Application in Effect After Review by FDA to Initiate Phase 1 Clinical Trial Evaluating First-in-Class OCU500 Inhaled Vaccine Candidate for COVID-19 (GlobeNewswire) -6.27%
05:31AM	Loading…
Jan-17-25 05:31AM	Ocugen doses first subject in Phase I trial of diabetic macular oedema treatment (Clinical Trials Arena)
Jan-16-25 07:30AM	Ocugen, Inc. Announces First Patient Dosed in Phase 1 Clinical Trial of OCU200 a Novel Integrin-Targeting Biologic for Diabetic Macular Edema (GlobeNewswire)
Jan-13-25 06:30AM	Ocugen, Inc. Announces Positive 2-Year Data Across Multiple Mutations from Phase 1/2 Clinical Trial of OCU400 A Novel Modifier Gene Therapy for Retinitis Pigmentosa (GlobeNewswire)
Dec-19-24 06:38AM	Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of OCU410 ArMaDa Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration (GlobeNewswire)
Dec-11-24 07:02AM	Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit (GlobeNewswire)
Nov-27-24 07:09AM	Ocugen CEO to Present at NobleCon20 Noble Capital Markets' 20th Annual Emerging Growth Equity Conference (GlobeNewswire) +6.74%
Nov-20-24 07:30AM	Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate OCU410ST for Treatment of ABCA4-Associated Retinopathies including Stargardt Disease (GlobeNewswire) +5.14%
Nov-19-24 07:02AM	Ocugen Announces Compelling Preliminary Data for OCU410 a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration (GlobeNewswire)
Nov-14-24 04:40PM	Ocugen (OCGN) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -6.14%
03:32PM	Ocugen: Q3 Earnings Snapshot (Associated Press Finance)
02:14AM	Loading…
Nov-09-24 02:14AM	Q3 2024 Ocugen Inc Earnings Call (Thomson Reuters StreetEvents)
02:05AM	Ocugen Inc (OCGN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges (GuruFocus.com)
Nov-08-24 11:15AM	Ocugen (OCGN) Q3 2024 Earnings Call Transcript (Motley Fool) -8.69%
06:45AM	Ocugen Provides Business Update with Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-07-24 06:30AM	Ocugen Secures $30 Million in Debt Funding (GlobeNewswire) +8.88%
Oct-28-24 06:30AM	Ocugen Clinical Showcase Highlighting Progress in Retinal Gene Therapy Clinical Trials in New York City on Tuesday, November 12, 2024 (GlobeNewswire) +9.24%
Oct-22-24 07:02AM	Data and Safety Monitoring Board Approves Initiation of Phase 2 of OCU410ST GARDian Clinical Trial for Stargardt Disease (GlobeNewswire)
Oct-17-24 07:30AM	Ocugen to Host Conference Call on Friday, November 8 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-16-24 03:03PM	State Street Corp's Strategic Acquisition of Shares in Ocugen Inc (GuruFocus.com)
Oct-10-24 07:00AM	Ocugen to Participate in 2024 Maxim Healthcare Virtual Summit (GlobeNewswire)
Oct-09-24 05:35PM	Ocugen Inc (OCGN) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges (GuruFocus.com)
06:30AM	Ocugen, Inc. Announces Removal of Clinical Hold on Investigational New Drug Application for OCU200 Phase 1 Clinical Trial (GlobeNewswire)
Oct-02-24 06:30AM	Ocugen to Present at the 2024 Cell & Gene Meeting on the Mesa (GlobeNewswire)
Sep-24-24 07:30AM	Ocugen to Participate in a Fireside Chat at Chardan's 8th Annual Genetic Medicines Conference (GlobeNewswire) -6.13%
Sep-09-24 06:30AM	Ocugen Chairman, CEO & Co-founder, Dr. Shankar Musunuri, to Speak During U.S.-India Initiative on Critical and Emerging Technology Workshop (GlobeNewswire) +9.65%
07:00AM	Loading…
Sep-05-24 07:00AM	Ocugen CSO to Participate in 5th Annual Gene Therapy for Ophthalmic Disorders Summit (GlobeNewswire)
Sep-03-24 07:30AM	Ocugen to Participate in a Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire) -6.92%
Aug-28-24 06:30AM	Ocugen Announces Completion of Dosing in Subjects with Stargardt Disease in High Dose Cohort of Phase 1/2 GARDian Clinical Trial of OCU410ST A Modifier Gene Therapy (GlobeNewswire)
Aug-26-24 07:02AM	Ocugen, Inc. Announces Health Canada Approval to Initiate Phase 3 Clinical Trial for OCU400 Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication (GlobeNewswire)
Aug-08-24 10:49PM	Q2 2024 Ocugen Inc Earnings Call (Thomson Reuters StreetEvents) +8.47%
05:30PM	Ocugen (OCGN) Q2 2024 Earnings Call Transcript (Motley Fool)
06:45AM	Ocugen Provides Business Update with Second Quarter 2024 Financial Results (GlobeNewswire)
06:27AM	Ocugen: Q2 Earnings Snapshot (Associated Press Finance)
Aug-05-24 06:30AM	Ocugen, Inc. Announces FDA Approval of Expanded Access Program for Patients with Retinitis Pigmentosa (GlobeNewswire)
Aug-02-24 03:22PM	Ocugen, Inc. Announces Closing of $35 Million Public Offering of Common Stock (GlobeNewswire) -5.77%
Jul-31-24 09:15PM	Ocugen, Inc. Announces Pricing of $35 Million Public Offering of Common Stock (GlobeNewswire) -7.47%
04:15PM	Ocugen, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Jul-29-24 07:02AM	Ocugen to Host Conference Call on Thursday, August 8 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2024 Financial Results (GlobeNewswire) -9.76%
Jul-25-24 06:30AM	Ocugen, Inc. Announces Completion of Dosing in Subjects with Geographic Atrophy Secondary to dAMD in High-Dose Cohort of Phase 1/2 ArMaDa Clinical Trial of OCU410-A Novel Modifier Gene Therapy (GlobeNewswire)
Jul-11-24 08:45AM	1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid (Motley Fool)
Jul-06-24 06:39AM	3 Penny Stocks That Could Turn $10K Into $100K in 3 Years (InvestorPlace)
Jun-24-24 09:40AM	Is Ocugen (OCGN) Stock Outpacing Its Medical Peers This Year? (Zacks) -5.26%
06:40AM	7 A-Rated Penny Stocks to Beat June Gloom (InvestorPlace)
Jun-21-24 07:00AM	Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease (GlobeNewswire)
Jun-20-24 08:23AM	3 Penny Stocks Set to Make New Millionaires in 2024 (InvestorPlace) -6.88%
06:30AM	Ocugen, Inc. Announces First Patient Dosed in Phase 3 liMeliGhT Clinical Trial for OCU400 First Gene Therapy in Phase 3 with a Broad Retinitis Pigmentosa Indication (GlobeNewswire)
Jun-14-24 07:15AM	7 A-Rated Biotech Stocks Worth Betting on in June (InvestorPlace) -6.58%
Jun-05-24 09:25AM	Ocugen (OCGN) Skyrockets 209.6% Year to Date: Heres Why (Zacks)
May-31-24 08:36AM	Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic Atrophy (GlobeNewswire) +8.81%
May-29-24 07:15AM	Ocugen to Present at BIO International Convention 2024 (GlobeNewswire)
May-28-24 07:02AM	Ocugen Set to Join Russell 3000 Index Effective June 28, 2024 (GlobeNewswire)
May-24-24 08:10AM	1 Stock That More Than Doubled This Year That I Wouldn't Touch With a 10-Foot Pole (Motley Fool)
May-20-24 07:00AM	Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024 (GlobeNewswire)
May-15-24 07:30AM	Ocugen Completes Dosing of Second Group in Stargardt Eye Therapy Safety and Efficacy Study (MT Newswires) +15.29%
06:30AM	Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST A Modifier Gene Therapy (GlobeNewswire)
03:02AM	Ocugen Inc (OCGN) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances Amid ... (GuruFocus.com)
01:12AM	Q1 2024 Ocugen Inc Earnings Call (Thomson Reuters StreetEvents)
May-14-24 11:53AM	OCGN Stock Earnings: Ocugen Beats EPS for Q1 2024 (InvestorPlace) -6.08%
08:00AM	Ocugen Provides Business Update with First Quarter 2024 Financial Results (GlobeNewswire)
06:43AM	Ocugen: Q1 Earnings Snapshot (Associated Press Finance)
May-10-24 04:05PM	Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock (GlobeNewswire) +13.84%
07:45AM	Ocugen to Present at May 2024 Investor Conferences (GlobeNewswire)
May-08-24 06:00AM	Millionaire Blueprint: 3 Stocks Under $5 With Massive Growth Potential by 2028 (InvestorPlace) +9.55%
May-03-24 07:30AM	Ocugen to Host Conference Call on Tuesday, May 14 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2024 Financial Results (GlobeNewswire)
May-02-24 07:15AM	Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress (GlobeNewswire) -5.04%
Apr-29-24 08:30AM	Can Ocugen Stock Keep Churning Higher? (Motley Fool) +8.59%
06:45AM	Ocugen Announces OCU400 Modifier Gene Therapy Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024 (GlobeNewswire)
Apr-28-24 11:59AM	5 ChatGPT Penny Stock Picks Right Now (Insider Monkey)
Apr-26-24 12:35PM	Ocugen (OCGN) to Report Q1 Earnings: What's in the Cards? (Zacks) +8.47%
09:05AM	UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting (GlobeNewswire)
06:30AM	Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting (GlobeNewswire)
Apr-19-24 07:13AM	Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410-A Modifier Gene Therapy (GlobeNewswire)
Apr-16-24 10:53PM	OCGN Stock Earnings: Ocugen Beats EPS for Q4 2023 (InvestorPlace) -9.43%
Apr-12-24 07:30AM	Ocugen to Participate in Fireside Chat at the Emerging Growth Virtual Healthcare Equity Conference, Presented by Noble Capital Markets (GlobeNewswire)
Apr-10-24 07:02AM	Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU400 Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication (GlobeNewswire) +5.26%
Apr-08-24 12:13PM	Ocugen (OCGN) Up as DSMB Allows Cohort 2 Dosing in GA Study (Zacks)
10:57AM	Why Is Ocugen (OCGN) Stock Up 7% Today? (InvestorPlace)
06:30AM	Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment to Initiate OCU400 Phase 3 Clinical Trial First Gene Therapy to Enter Phase 3 with a Broad Retinitis Pigmentosa Indication (GlobeNewswire)
Apr-05-24 03:30PM	OCGN Stock Alert: Why Is Ocugen Up 20% Today? (InvestorPlace) +21.19%
07:02AM	Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410 a Modifier Gene Therapy in Phase 1/2 ArMaDa Study for Geographic Atrophy (GlobeNewswire)
Apr-02-24 10:50PM	Q4 2023 Ocugen Inc Earnings Call (Thomson Reuters StreetEvents) -10.39% +9.06%
07:00PM	Ocugen (OCGN) Q4 2023 Earnings Call Transcript (Motley Fool)
03:15PM	OCGN Stock Falls Ocugen Must Restate Its Financials (InvestorPlace)
08:00AM	Ocugen Provides Business Update with Certain Financials for the Year Ending 2023 (GlobeNewswire)
Apr-01-24 06:08PM	Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410ST a Modifier Gene Therapy in GARDian Study for Stargardt Disease (GlobeNewswire) -6.10%
05:43PM	Ocugen to Host Conference Call on Tuesday, April 2 at 8:30 A.M. ET to Provide Business Update with Certain Financials for the Year Ending 2023 (GlobeNewswire)
Mar-25-24 11:58AM	Why Is Ocugen (OCGN) Stock Up 20% Today? (InvestorPlace) +11.59%
07:32AM	3 Stocks Under $5 Ready to Outpace the Market (InvestorPlace)
Mar-18-24 06:30AM	Ocugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical Officer (GlobeNewswire)
Mar-13-24 08:00AM	Ocugen, Inc. Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410 (GlobeNewswire) +5.69%
Mar-07-24 05:28AM	Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street (Motley Fool) +16.09%
Mar-06-24 07:30AM	Ocugen to Present at Investing in Cures Summit (GlobeNewswire)
Feb-28-24 08:00AM	Ocugen Clinical Showcase Webcast Now Available (GlobeNewswire)
Feb-26-24 04:34PM	Meme Stock Meltdowns: 3 Names to Sell Before They Crash (InvestorPlace) +13.28% +10.00%
08:30AM	Ocugen Chairman and CEO to present at Abu Dhabi Family Office Summit (GlobeNewswire)

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Fernandes Prabhavathi	Director	Nov 26 '24	Buy	0.91	10,000	9,095	10,000	Dec 02 04:15 PM
Castillo Kirsten	Director	Nov 22 '24	Buy	0.91	25,000	22,848	75,000	Nov 26 04:50 PM
RAMESH KUMAR	Director	Aug 16 '24	Proposed Sale	1.25	116,705	145,905		Aug 16 04:16 PM

Dollar change -1.01
Percentage change -5.41	%

Peers: CPRT KAR LAD CVNA AN ABG VRM GPI TRUE PAG

| Held by: VTI VB IWM VXF VBK IWO SCHA VTWO DFAS VIS

Index	RUT	P/E	-	EPS (ttm)	-0.48	Insider Own	8.39%	Shs Outstand	178.13M	Perf Week	-18.55%
Market Cap	3.13B	Forward P/E	35.49	EPS next Y	0.50	Insider Trans	-11.30%	Shs Float	163.18M	Perf Month	-17.98%
Income	-79.70M	PEG	-	EPS next Q	-0.02	Inst Own	92.45%	Short Float	5.36%	Perf Quarter	-20.03%
Sales	637.16M	P/S	4.92	EPS this Y	263.62%	Inst Trans	2.68%	Short Ratio	6.18	Perf Half Y	-7.06%
Book/sh	2.73	P/B	6.44	EPS next Y	94.54%	ROA	-8.36%	Short Interest	8.75M	Perf Year	25.25%
Cash/sh	1.52	P/C	11.60	EPS next 5Y	145.34%	ROE	-17.78%	52W Range	13.66 - 23.46	Perf YTD	-18.59%
Dividend Est.	-	P/FCF	51.47	EPS past 5Y	0.70%	ROI	-14.16%	52W High	-25.03%	Beta	1.68
Dividend TTM	-	Quick Ratio	1.51	Sales past 5Y	46.24%	Gross Margin	46.44%	52W Low	28.73%	ATR (14)	0.92
Dividend Ex-Date	-	Current Ratio	1.56	EPS Y/Y TTM	-2.74%	Oper. Margin	-12.40%	RSI (14)	24.48	Volatility	5.99% 4.01%
Employees	2170	Debt/Eq	0.28	Sales Y/Y TTM	32.40%	Profit Margin	-12.51%	Recom	1.46	Target Price	24.32
Option/Short	Yes / Yes	LT Debt/Eq	0.28	EPS Q/Q	-8.88%	Payout	-	Rel Volume	2.52	Prev Close	18.59
Sales Surprise	1.73%	EPS Surprise	-41.43%	Sales Q/Q	34.75%	Earnings	Feb 19 AMC	Avg Volume	1.42M	Price	17.58
SMA20	-15.85%	SMA50	-16.83%	SMA200	-9.26%	Trades		Volume	3,568,069	Change	-5.41%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-22-25	Initiated	Stephens	Equal-Weight	$20.50
Sep-27-24	Resumed	Raymond James	Mkt Perform	$22
Jun-10-24	Upgrade	JP Morgan	Neutral → Overweight	$21
Jan-10-24	Upgrade	Northcoast	Neutral → Buy	$22
Jul-20-23	Initiated	B. Riley Securities	Buy	$23
Jul-13-23	Downgrade	JP Morgan	Overweight → Neutral	$17
Feb-16-23	Downgrade	Piper Sandler	Overweight → Neutral	$11
Jun-30-22	Resumed	JMP Securities	Mkt Outperform
Jun-10-22	Initiated	Barrington Research	Outperform	$18
Apr-20-22	Resumed	Citigroup	Buy	$20
Mar-02-22	Upgrade	Stephens	Equal-Weight → Overweight	$17 → $19
Mar-01-22	Initiated	Needham	Buy	$20
Jan-07-22	Initiated	Goldman	Buy	$26
Oct-29-21	Initiated	Truist	Buy	$30
Aug-23-21	Upgrade	Citigroup	Neutral → Buy	$29 → $23
Aug-18-21	Upgrade	Piper Sandler	Neutral → Overweight	$30 → $26
Aug-13-21	Upgrade	BofA Securities	Neutral → Buy	$33 → $35
Aug-04-21	Upgrade	JP Morgan	Neutral → Overweight	$30
Apr-19-21	Initiated	Raymond James	Mkt Perform
Apr-19-21	Initiated	Piper Sandler	Neutral	$36

Show Previous Ratings

Feb-21-25 04:30PM	Carvana Pulls The Emergency Brake As Online Car Sellers Collapse (Investor's Business Daily) -5.41%
12:00PM	Three Online Car Sellers Sink On Weak Guidance, Led By Carvana (Investor's Business Daily)
12:00PM	Three Online Car Retailers Sink On Weak Guidance, Led By Carvana (Investor's Business Daily)
07:26AM	Why ACV Auctions Inc. (ACVA) Crashed on Thursday (Insider Monkey)
Feb-20-25 04:11PM	Carvana Earnings Surge 498% But Key Metric Weakens; CarGurus Due (Investor's Business Daily) -9.98%
01:50PM	Loading…
01:50PM	Why ACV Auctions (ACVA) Stock Is Down Today (StockStory)
08:03AM	Q4 2024 ACV Auctions Inc Earnings Call (Thomson Reuters StreetEvents)
02:13AM	ACV Auctions Inc (ACVA) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Feb-19-25 06:00PM	ACV Auctions Inc. (ACVA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:45PM	ACV Auctions (NASDAQ:ACVA) Beats Q4 Sales Targets But Stock Drops (StockStory)
04:05PM	ACV Announces Fourth Quarter and Full-Year 2024 Results (GlobeNewswire)
04:36AM	ACV Auctions Inc (ACVA) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Feb-18-25 08:01AM	ACV Auctions (ACVA) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory)
Feb-12-25 04:01AM	Spotting Winners: eHealth (NASDAQ:EHTH) And Online Marketplace Stocks In Q3 (StockStory)
04:01AM	Online Marketplace Stocks Q3 Highlights: ACV Auctions (NASDAQ:ACVA) (StockStory)
04:05PM	Loading…
Jan-22-25 04:05PM	ACV to Report Fourth Quarter 2024 Financial Results on February 19, 2025, and Host Analyst Day on March 11, 2025 (GlobeNewswire)
04:04AM	3 Reasons Were Fans of ACV Auctions (ACVA) (StockStory)
Jan-21-25 09:30AM	ACV to Showcase AI-Powered Data Solutions at 2025 National Automobile Dealers Association Conference (GlobeNewswire)
Dec-22-24 03:20PM	Why ACV Auctions (ACVA) Is Among the Best Auto and Truck Dealership Stocks to Invest In? (Insider Monkey)
Dec-21-24 12:18PM	Google Leads Five Stocks Near Buy Points, Standing Tall In Tricky Market (Investor's Business Daily)
Nov-28-24 07:10AM	ACV Auctions price target raised to $27 from $22 at Citi (TipRanks)
Nov-18-24 04:05PM	ACV to Participate in the 4th Annual Needham Consumer Tech / Ecommerce Virtual Conference (GlobeNewswire) +6.13%
Nov-15-24 08:00AM	Carvana Stock Rival ACV Auctions Is 'Coiled Spring' Under The Hood Of Used Car Business (Investor's Business Daily)
Nov-08-24 12:56PM	Q3 2024 ACV Auctions Inc Earnings Call (Thomson Reuters StreetEvents)
02:33AM	ACV Auctions Inc (ACVA) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com)
Nov-07-24 07:00PM	ACV Auctions Inc. (ACVA) Q3 Earnings and Revenues Surpass Estimates (Zacks)
04:25PM	ACV Auctionss (NASDAQ:ACVA) Q3: Beats On Revenue, Stock Soars (StockStory)
04:05PM	ACV Announces Third Quarter 2024 Results (GlobeNewswire)
Nov-06-24 07:12AM	ACV Auctions Inc (ACVA) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com) +8.07%
02:13AM	ACV Auctions (ACVA) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
04:05PM	Loading…
Oct-23-24 04:05PM	ACV to Report Third Quarter 2024 Financial Results on November 7, 2024 (GlobeNewswire)
Oct-14-24 04:55AM	Spotting Winners: ACV Auctions (NASDAQ:ACVA) And Online Marketplace Stocks In Q2 (StockStory)
Oct-13-24 11:32AM	Is ACV Auctions Inc. (ACVA) the Best Used Car Stock to Buy According to Hedge Funds? (Insider Monkey)
Oct-08-24 09:40AM	Are Retail-Wholesale Stocks Lagging ACV Auctions (ACVA) This Year? (Zacks)
Oct-07-24 04:45PM	ACV Showcases Consumer Vehicle Acquisition Solutions at Digital Dealer Conference & Expo (GlobeNewswire)
Sep-20-24 09:40AM	Is ACV Auctions (ACVA) Stock Outpacing Its Retail-Wholesale Peers This Year? (Zacks)
04:47AM	Q2 Earnings Highs And Lows: Teladoc (NYSE:TDOC) Vs The Rest Of The Online Marketplace Stocks (StockStory)
Aug-21-24 07:03PM	Insider Sale: Chief Legal Officer Leanne Fitzgerald Sells Shares of ACV Auctions Inc (ACVA) (GuruFocus.com)
Aug-19-24 09:40AM	Is ACV Auctions (ACVA) Stock Outpacing Its Retail-Wholesale Peers This Year? (Zacks)
Aug-07-24 07:30PM	ACV Auctions (ACVA) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks) +21.71%
06:55PM	ACV Auctions Inc. (ACVA) Meets Q2 Earnings Estimates (Zacks)
04:35PM	ACV Auctions (NASDAQ:ACVA) Beats Q2 Sales Targets, Provides Encouraging Quarterly Guidance (StockStory)
04:06PM	ACV Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
04:05PM	ACV Announces Second Quarter 2024 Results (GlobeNewswire)
Aug-06-24 09:15AM	Curious about ACV Auctions (ACVA) Q2 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
03:03AM	What To Expect From ACV Auctions's (ACVA) Q2 Earnings (StockStory)
Jul-31-24 10:01AM	ACV Auctions Inc. (ACVA) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-24-24 04:05PM	ACV to Report Second Quarter 2024 Financial Results on August 7, 2024 (GlobeNewswire)
Jul-15-24 03:39AM	Reflecting On Online Marketplace Stocks Q1 Earnings: ACV Auctions (NASDAQ:ACVA) (StockStory)
Jun-26-24 07:01AM	ACV Auctions (ACVA) Surged on Robust Results and 2024 Guidance (Insider Monkey)
Jun-13-24 03:17AM	Insider Selling: Director Brian Hirsch Sells 22,958 Shares of ACV Auctions Inc (ACVA) (GuruFocus.com)
Jun-11-24 01:52AM	Insider Sale: Director Brian Hirsch Sells 72,462 Shares of ACV Auctions Inc (ACVA) (GuruFocus.com)
May-16-24 04:17PM	Acv Auctions Insider Sold Shares Worth $574,925, According to a Recent SEC Filing (MT Newswires)
May-14-24 06:11AM	Q1 2024 Rand Capital Corp Earnings Call (Thomson Reuters StreetEvents)
03:02AM	Rand Capital Corp (RAND) (Q1 2024) Earnings Call Transcript Highlights: Strategic Shifts and ... (GuruFocus.com)
May-10-24 05:44PM	ACV Auctions Inc. (NASDAQ:ACVA) Q1 2024 Earnings Call Transcript (Insider Monkey)
01:00PM	ACV Auctions Inc. Reports First Quarter 2024 Results: Revenue Growth Surpasses Estimates (GuruFocus.com)
May-09-24 10:08AM	Piper Sandler Adjusts Price Target on ACV Auctions to $16 From $15, Maintains Neutral Rating (MT Newswires)
09:23AM	Q1 2024 ACV Auctions Inc Earnings Call (Thomson Reuters StreetEvents)
08:41AM	B. Riley Adjusts Price Target on ACV Auctions to $24 From $23, Maintains Buy Rating (MT Newswires)
08:00AM	ACV to Participate in Upcoming Investor Conferences (GlobeNewswire)
04:02AM	ACV Auctions Inc (ACVA) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations ... (GuruFocus.com)
May-08-24 10:56PM	ACVA Stock Earnings: ACV Auctions Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:30PM	ACV Auctions (ACVA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:55PM	ACV Auctions Inc. (ACVA) Reports Break-Even Earnings for Q1 (Zacks)
04:35PM	ACV Auctions (NASDAQ:ACVA) Posts Better-Than-Expected Sales In Q1 But Quarterly Guidance Underwhelms (StockStory)
04:05PM	ACV's Data-Driven Solutions Drive Profits and Optimize Inventory for Dealerships (GlobeNewswire)
04:05PM	ACV Announces First Quarter 2024 Results (GlobeNewswire)
May-07-24 03:03AM	What To Expect From ACV Auctions's (ACVA) Q1 Earnings (StockStory)
May-06-24 09:16AM	Countdown to ACV Auctions (ACVA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Apr-26-24 07:00AM	Used-Car Sales Have Moved OnlineHeres Why Both Customers and Dealers Are Happy (The Wall Street Journal)
Apr-24-24 04:05PM	ACV to Report First Quarter 2024 Financial Results on May 8, 2024 (GlobeNewswire)
Apr-15-24 08:05AM	ACV Transportation Expands Services to Vehicles Purchased Outside of the ACV Platform (GlobeNewswire)
Apr-05-24 07:00PM	Insider Sell: COO Vikas Mehta Sells 121,741 Shares of ACV Auctions Inc (ACVA) (GuruFocus.com)
Apr-04-24 01:31AM	Insider Sell: COO Vikas Mehta Sells 78,259 Shares of ACV Auctions Inc (ACVA) (GuruFocus.com)
Apr-02-24 08:03AM	Does ACV Auctions (ACVA) Have the Potential to Create a Strong Competitive Moat? (Insider Monkey)
Mar-22-24 01:53AM	ACV Auctions Inc CFO William Zerella Sells 32,500 Shares (GuruFocus.com)
01:53AM	ACV Auctions Inc CEO George Chamoun Sells Over 300,000 Shares (GuruFocus.com)
Mar-20-24 08:29PM	Fuel Me Secures $18 Million in Oversubscribed Series A to Redefine Fuel Procurement as We Know It (PR Newswire)
Feb-28-24 08:00AM	ACV to Participate in The Citizens JMP Technology Conference (GlobeNewswire)
Feb-27-24 08:19AM	ACV Auctions Inc. (NASDAQ:ACVA) Q4 2023 Earnings Call Transcript (Insider Monkey) +7.14%
Feb-23-24 04:05PM	Carvana Stock Soars With Earnings Outlook Seen 'Driving The Squeeze' (Investor's Business Daily)
12:51PM	Carvana Stock Drives Past Buy Point As Earnings Outlook 'Trumps' Mixed Report (Investor's Business Daily)
11:00AM	Carvana Stock Soars Above Buy Point As Earnings Outlook 'Trumps' Mixed Report (Investor's Business Daily)
Feb-22-24 05:56PM	Carvana Stock Soars As Online Used-Car Seller Guides High (Investor's Business Daily) +17.21%
05:56PM	Why ACV Auctions Stock Popped Today (Motley Fool)
04:50PM	Carvana Stock Soars After Guiding Higher Used Car Sales, Earnings In 2024 (Investor's Business Daily)
04:05PM	Carvana Stock Pops With Earnings On Deck. A Used-Car Auction Peer Soars. (Investor's Business Daily)
01:16PM	Carvana Stock Rises With Earnings On Deck. A Used-Car Auction Peer Beats And Soars. (Investor's Business Daily)
07:53AM	Q4 2023 ACV Auctions Inc Earnings Call (Thomson Reuters StreetEvents)
05:00AM	7 Unstoppable Software Stocks Set to Soar in 2024 (InvestorPlace)
Feb-21-24 06:30PM	ACV Auctions Inc. (ACVA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:50PM	ACV Auctions Inc. (ACVA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	ACV Auctions Announces the Settlement of Litigation Regarding AutoIMS (GlobeNewswire)
04:05PM	ACV Announces Fourth Quarter and Full-Year 2023 Results (GlobeNewswire)
Feb-19-24 09:15AM	ACV Auctions Inc. (ACVA) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
Feb-09-24 01:40AM	ACV Auctions Inc CFO William Zerella Sells 32,500 Shares (GuruFocus.com)
Feb-07-24 07:09AM	Baron Discovery Fund Sold ACV Auctions (ACVA) Due to the Current Valuation (Insider Monkey)
Feb-02-24 05:00AM	3 Growth Stocks Poised for a 2024 Millionaire-Making Moonshot (InvestorPlace)
Feb-01-24 09:15AM	Impel Launches Car Buying AI and Integrates with ACV Auctions' ClearCar to Bring Enhanced Inventory Acquisition Solution to Auto Dealers (PR Newswire)

ACV Auctions, Inc. provides a vibrant digital marketplace for wholesale vehicle transactions and data services, which offers transparent and accurate vehicle information to its customers. The company's platform leverages data insights and technology to power its digital marketplace and data services, enabling its dealers and commercial partners to buy, sell and value vehicles. Its platform includes Digital Marketplace, Remarketing Centers, Data Services and Data and Technology. Digital Marketplace connects buyers and sellers of wholesale vehicles in an intuitive and efficient manner. Remarketing Centers provides an additional channel to provide dealers and commercial partners with auction services. Data Services offers insights into the condition and value of used vehicles for transactions both on and off its marketplace and helps dealers, their end consumers, and commercial partners make more informed decisions to transact with confidence and efficiency. Data and Technology underpins everything it does, and powers its vehicle inspections, comprehensive vehicle intelligence reports, digital marketplace and operations automation platform. The company was founded by Joseph Neiman, Daniel Magnuszewsk, and Jack Greco in December 2014 and is headquartered in Buffalo, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chamoun George	Chief Executive Officer	Feb 05 '25	Option Exercise	0.14	150,000	21,000	989,326	Feb 07 04:22 PM
Waterman Michael	Chief Sales Officer	Feb 04 '25	Sale	20.27	15,000	304,050	311,354	Feb 06 04:07 PM
ZERELLA WILLIAM	Chief Financial Officer	Feb 04 '25	Sale	20.63	15,000	309,450	447,452	Feb 06 04:05 PM
ZERELLA WILLIAM	Chief Financial Officer	Jan 07 '25	Sale	20.57	15,000	308,550	462,452	Jan 10 04:11 PM
Waterman Michael	Chief Sales Officer	Jan 07 '25	Sale	20.53	30,162	619,226	314,738	Jan 10 04:09 PM
Waterman Michael	Chief Sales Officer	Jan 08 '25	Sale	20.24	9,985	202,096	311,354	Jan 10 04:09 PM
MICHAEL WATERMAN	Officer	Jan 08 '25	Proposed Sale	20.30	9,985	202,696		Jan 08 04:22 PM
MICHAEL WATERMAN	Officer	Jan 07 '25	Proposed Sale	21.11	45,162	953,370		Jan 07 04:19 PM
WILLIAM ZERELLA	Officer	Jan 07 '25	Proposed Sale	21.11	45,000	949,950		Jan 07 04:18 PM
ZERELLA WILLIAM	Chief Financial Officer	Dec 30 '24	Sale	21.65	32,500	703,625	490,482	Dec 31 04:45 PM
WILLIAM ZERELLA	Officer	Dec 30 '24	Proposed Sale	21.80	32,500	708,500		Dec 30 04:11 PM
Chamoun George	Chief Executive Officer	Dec 10 '24	Sale	21.64	210,400	4,553,056	872,404	Dec 12 04:19 PM
Chamoun George	Chief Executive Officer	Dec 11 '24	Sale	21.66	139,600	3,023,736	872,404	Dec 12 04:19 PM
Waterman Michael	Chief Sales Officer	Dec 10 '24	Sale	21.81	15,000	327,150	337,842	Dec 12 04:17 PM
Anderson Craig Eric	CCDSO	Dec 09 '24	Sale	22.28	240,563	5,359,744	258,546	Dec 11 04:21 PM
GEORGE G CHAMOUN	Director	Dec 10 '24	Proposed Sale	22.15	350,000	7,752,500		Dec 10 04:28 PM
CRAIG ANDERSON	Officer	Dec 09 '24	Proposed Sale	22.34	248,051	5,541,459		Dec 09 04:42 PM
ZERELLA WILLIAM	Chief Financial Officer	Nov 26 '24	Sale	22.41	32,500	728,325	490,482	Nov 27 04:16 PM
WILLIAM ZERELLA	Officer	Nov 26 '24	Proposed Sale	22.96	32,500	746,200		Nov 26 04:25 PM
15 Angels III LLC	Director	Nov 18 '24	Proposed Sale	20.72	27,071	560,911		Nov 18 04:32 PM
Bessemer Venture Partners IX I	Director	Nov 18 '24	Proposed Sale	20.72	1,308,933	27,121,092		Nov 18 04:30 PM
Bessemer Venture Partners IX L	Director	Nov 18 '24	Proposed Sale	20.72	1,633,816	33,852,668		Nov 18 04:28 PM
Waterman Michael	Chief Sales Officer	Nov 12 '24	Sale	20.91	21,483	449,210	337,190	Nov 14 04:06 PM
Hirsch Brian	Director	Nov 12 '24	Sale	20.69	146,681	3,034,830	9,239	Nov 13 04:15 PM
Hirsch Brian	Affiliate	Nov 12 '24	Proposed Sale	21.10	146,681	3,094,969		Nov 12 04:56 PM
MICHAEL WATERMAN	Officer	Nov 12 '24	Proposed Sale	21.10	30,000	633,000		Nov 12 04:27 PM
ZERELLA WILLIAM	Chief Financial Officer	Oct 15 '24	Sale	18.79	32,500	610,675	490,482	Oct 17 04:43 PM
Waterman Michael	Chief Sales Officer	Oct 15 '24	Sale	18.79	18,001	338,239	337,190	Oct 17 04:39 PM
MICHAEL WATERMAN	Officer	Oct 15 '24	Proposed Sale	18.75	18,001	337,519		Oct 15 04:30 PM
WILLIAM ZERELLA	Officer	Oct 15 '24	Proposed Sale	18.75	32,500	609,375		Oct 15 04:30 PM
Waterman Michael	Chief Sales Officer	Oct 01 '24	Sale	19.95	16,098	321,155	348,155	Oct 03 05:29 PM
MICHAEL WATERMAN	Officer	Oct 01 '24	Proposed Sale	20.33	22,581	459,072		Oct 01 04:33 PM
Peer Andrew	VP, Corporate Controller	Sep 19 '24	Sale	21.00	1,795	37,695	62,956	Sep 23 04:37 PM
Chamoun George	Chief Executive Officer	Sep 18 '24	Sale	20.37	238,637	4,861,036	928,166	Sep 19 05:40 PM
Chamoun George	Chief Executive Officer	Sep 17 '24	Sale	20.27	111,363	2,257,328	928,166	Sep 19 05:40 PM
Waterman Michael	Chief Sales Officer	Sep 17 '24	Sale	20.24	75,000	1,518,000	366,710	Sep 19 05:35 PM
ANDREW PEER	Director	Sep 19 '24	Proposed Sale	20.25	1,795	36,349		Sep 19 04:25 PM
ZERELLA WILLIAM	Chief Financial Officer	Sep 17 '24	Sale	20.26	76,856	1,557,103	503,077	Sep 18 05:24 PM
ZERELLA WILLIAM	Chief Financial Officer	Sep 18 '24	Sale	20.45	5,644	115,420	503,077	Sep 18 05:24 PM
GEORGE G CHAMOUN	Director	Sep 17 '24	Proposed Sale	19.95	350,000	6,982,500		Sep 17 04:39 PM
MICHAEL WATERMAN	Officer	Sep 17 '24	Proposed Sale	19.95	75,000	1,496,250		Sep 17 04:39 PM
WILLIAM ZERELLA	Officer	Sep 17 '24	Proposed Sale	19.95	82,500	1,645,875		Sep 17 04:38 PM
Anderson Craig Eric	CCDSO	Sep 12 '24	Sale	20.00	7,500	150,000	328,167	Sep 16 04:34 PM
Peer Andrew	VP, Corporate Controller	Sep 12 '24	Sale	20.00	1,601	32,020	64,751	Sep 16 04:31 PM
Mehta Vikas	Chief Operating Officer	Sep 10 '24	Sale	19.19	154,324	2,961,478	432,457	Sep 12 06:49 PM
CRAIG ANDERSON	Officer	Sep 12 '24	Proposed Sale	19.68	7,500	147,600		Sep 12 04:29 PM
ANDREW PEER	Director	Sep 12 '24	Proposed Sale	19.68	1,601	31,508		Sep 12 04:29 PM
VIKAS MEHTA	Officer	Sep 10 '24	Proposed Sale	19.25	154,324	2,970,737		Sep 10 04:23 PM
Peer Andrew	VP, Corporate Controller	Sep 04 '24	Sale	18.14	573	10,394	66,352	Sep 06 04:16 PM
KAMERICK EILEEN A	Director	Sep 04 '24	Sale	17.83	25,000	445,750	9,239	Sep 06 04:11 PM
EILEEN A KAMERICK	Director	Sep 04 '24	Proposed Sale	17.83	25,000	445,720		Sep 04 04:21 PM
ANDREW PEER	Director	Sep 04 '24	Proposed Sale	18.15	573	10,400		Sep 04 04:15 PM
Mehta Vikas	Chief Operating Officer	Aug 23 '24	Sale	18.71	145,928	2,730,313	468,505	Aug 27 04:37 PM
Mehta Vikas	Chief Operating Officer	Aug 26 '24	Sale	19.21	8,395	161,268	467,090	Aug 27 04:37 PM
15 Angels III LLC	Director	Aug 26 '24	Proposed Sale	18.96	13,671	259,202		Aug 26 05:03 PM
Bessemer Venture Partners IX I	Director	Aug 26 '24	Proposed Sale	18.96	661,119	12,534,816		Aug 26 05:01 PM
Bessemer Venture Partners IX L	Director	Aug 26 '24	Proposed Sale	18.96	825,210	15,645,982		Aug 26 04:59 PM
Hirsch Brian	Director	Aug 23 '24	Sale	18.63	61,666	1,148,838	9,239	Aug 23 05:11 PM
VIKAS MEHTA	Officer	Aug 23 '24	Proposed Sale	18.26	154,323	2,817,938		Aug 23 04:26 PM
15 Angels III LLC	Director	Aug 23 '24	Proposed Sale	18.26	4,557	83,211		Aug 23 04:15 PM
Bessemer Venture Partners IX I	Director	Aug 23 '24	Proposed Sale	18.26	220,373	4,024,011		Aug 23 04:13 PM
Bessemer Venture Partners IX L	Director	Aug 23 '24	Proposed Sale	18.26	275,070	5,022,778		Aug 23 04:11 PM
Hirsch Brian	Affiliate	Aug 23 '24	Proposed Sale	18.26	61,666	1,126,021		Aug 23 04:01 PM
Fitzgerald Leanne	Chief Legal Officer	Aug 20 '24	Sale	18.85	73,167	1,379,198	377,071	Aug 21 04:14 PM
15 Angels III LLC	Director	Aug 20 '24	Proposed Sale	18.62	4,557	84,851		Aug 20 05:36 PM
Bessemer Venture Partners IX I	Director	Aug 20 '24	Proposed Sale	18.62	220,373	4,103,345		Aug 20 05:33 PM
Bessemer Venture Partners IX L	Director	Aug 20 '24	Proposed Sale	18.62	275,070	5,121,803		Aug 20 05:30 PM
LEANNE FITZGERALD	Officer	Aug 20 '24	Proposed Sale	18.62	73,167	1,362,370		Aug 20 04:26 PM
Peer Andrew	VP, Corporate Controller	Aug 15 '24	Sale	19.00	1,150	21,850	8,336	Aug 19 04:28 PM
15 Angels III LLC	Director	Aug 16 '24	Proposed Sale	18.61	4,557	84,805		Aug 16 05:43 PM
Bessemer Venture Partners IX L	Director	Aug 16 '24	Proposed Sale	18.62	275,070	5,121,803		Aug 16 05:41 PM
Bessemer Venture Partners IX I	Director	Aug 16 '24	Proposed Sale	18.62	220,373	4,103,345		Aug 16 05:34 PM
ANDREW PEER	Director	Aug 15 '24	Proposed Sale	18.16	1,150	20,884		Aug 15 04:28 PM
15 Angels III LLC	Director	Aug 14 '24	Proposed Sale	18.35	4,557	83,621		Aug 14 04:53 PM
Bessemer Venture Partners IX I	Director	Aug 14 '24	Proposed Sale	18.35	220,373	4,043,845		Aug 14 04:52 PM
Bessemer Venture Partners IX L	Director	Aug 14 '24	Proposed Sale	18.35	275,070	5,047,535		Aug 14 04:48 PM
ZERELLA WILLIAM	Chief Financial Officer	Aug 06 '24	Sale	15.19	32,500	493,675	503,077	Aug 08 04:28 PM
WILLIAM ZERELLA	Officer	Aug 06 '24	Proposed Sale	15.15	32,500	492,375		Aug 06 04:08 PM
ZERELLA WILLIAM	Chief Financial Officer	Jul 09 '24	Sale	17.51	32,500	569,075	503,077	Jul 11 06:06 PM
Waterman Michael	Chief Sales Officer	Jul 09 '24	Sale	17.51	26,336	461,143	366,710	Jul 11 06:05 PM
Anderson Craig Eric	CCDSO	Jul 02 '24	Sale	17.81	7,500	133,575	328,167	Jul 03 04:59 PM
Chamoun George	Chief Executive Officer	Jun 21 '24	Sale	17.71	140,525	2,488,698	961,245	Jun 21 05:55 PM
Chamoun George	Chief Executive Officer	Jun 20 '24	Sale	17.62	131,480	2,316,678	961,245	Jun 21 05:55 PM
Chamoun George	Chief Executive Officer	Jun 18 '24	Sale	17.71	77,995	1,381,291	961,245	Jun 21 05:55 PM
ZERELLA WILLIAM	Chief Financial Officer	Jun 11 '24	Sale	18.13	276,900	5,019,547	515,671	Jun 13 04:08 PM
ZERELLA WILLIAM	Chief Financial Officer	Jun 12 '24	Sale	18.66	123,700	2,308,242	515,671	Jun 13 04:08 PM
Hirsch Brian	Director	Jun 11 '24	Sale	18.13	22,958	416,229	9,239	Jun 12 09:21 PM
Hirsch Brian	Director	Jun 10 '24	Sale	18.33	57,211	1,048,678	32,197	Jun 10 08:13 PM
Hirsch Brian	Director	Jun 07 '24	Sale	18.02	14,909	268,660	89,408	Jun 10 08:13 PM
Hirsch Brian	Director	Jun 06 '24	Sale	18.03	342	6,166	104,317	Jun 10 08:13 PM
Castillo Kirsten	Director	Jun 06 '24	Sale	17.68	15,000	265,200	9,239	Jun 10 05:49 PM
Castillo Kirsten	Director	Jun 07 '24	Sale	17.82	5,000	89,100	9,239	Jun 10 05:49 PM
Hirsch Brian	Director	May 31 '24	Sale	18.25	100	1,825	104,659	Jun 04 06:50 PM
Hirsch Brian	Director	May 29 '24	Sale	18.29	8,221	150,362	95,520	May 30 07:07 PM
Waterman Michael	Chief Sales Officer	May 29 '24	Sale	18.00	46,126	830,268	335,672	May 30 04:45 PM
ZERELLA WILLIAM	Chief Financial Officer	May 14 '24	Sale	17.69	32,500	574,925	314,151	May 16 04:14 PM
ZERELLA WILLIAM	Chief Financial Officer	Apr 16 '24	Sale	17.17	32,500	558,025	314,151	Apr 17 05:20 PM
Anderson Craig Eric	CCDSO	Apr 09 '24	Sale	18.50	7,500	138,750	194,525	Apr 11 04:09 PM
Mehta Vikas	Chief Operating Officer	Apr 03 '24	Sale	18.40	108,342	1,993,493	321,475	Apr 05 04:12 PM
Mehta Vikas	Chief Operating Officer	Apr 04 '24	Sale	18.55	13,399	248,551	321,475	Apr 05 04:12 PM

OCGN

Ocugen Inc

ACVA

ACV Auctions Inc

Upgrade your FINVIZ experience